SCD1 is the rate‐limiting enzyme of MUFAs and is closely related to the accumulation of lipid droplets, and the inhibition of SCD1 can delay tumor progression and drug resistance.[11, 12, 13, 14]. Here, SCD is linked to neoplasm.